We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Bacteria-Based Test Strips Can Monitor Blood Glucose

By LabMedica International staff writers
Posted on 26 Jan 2012
Segments of DNA embedded in bacteria can be coded to detect changes in osmolarity resulting from the presence of glucose in a blood sample.

Students at the Missouri University of Science and Technology (MST, Rolla, USA) used a nonvirulent strain of E.coli with designed genes integrated in the bacteria’s DNA, enabling them to sense the presence of glucose in correlation to changes in osmolarity. More...
When glucose is detected, the bacteria emit a yellow glow, and as its concentration rises, so does the light emitted glow brighter. The system might also eventually serve as the basis for a new method to monitor blood glucose levels by replacing the fluorescent gene with one that would make the bacteria change color, based on glucose concentrations.

To make the device, the students used an intermediate biobrick with a ribosome-binding site and the reporter gene (eYFP), which was then coupled to another biobrick that had three binding sites for the transcriptional regulatory protein phosphorylated OmpR. The phosphorlyation of OmpR by EnvZ (an inner membrane protein that senses osmolarity) positively correlated with the osmolarity of the system. When one or two of the binding sites are occupied, RNA polymerase is recruited to begin downstream transcription of eYFP. However, when all three OmpR binding sites are occupied, RNA polymerase cannot bind, the reporter gene can no longer be produced, and the system is inhibited.

As osmolarity increases from very low levels, the fluorescence produced by the system increases, until it reaches a threshold osmolarity level that when crossed causes the fluorescence to decrease as a result of the ensuing inherent down-regulation of the system. The activity of the system can be quantified because the two-component regulatory system of EnvZ and OmpR controls transcription of the eYFP gene, dictating the level of fluorescence.

“All you would have to do is put the DNA inside a bacteria and you've got your test strip,” said Erica Shannon, a senior year student in biological sciences at MST. “In the future, based on further research, an insulin gene could be added to this system for use in insulin pumps, where specific glucose levels trigger insulin production.”

The project was developed the system as part of an annual competition sponsored by the International Genetically Engineered Machine Foundation (iGEM; Boston, MA, USA) held during October 2011, in Indianapolis (IN, USA); the MST iGEM chapter received a silver medal for their effort.

Related Links:

Missouri University of Science and Technology
International Genetically Engineered Machine Foundation




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.